Form 4: Quest Diagnostics SVP Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Mark A. Gardner, SVP of Molecular Gen & Oncol at Quest Diagnostics, sold 262 shares of common stock on February 28, 2024, to cover tax obligations arising from vesting restricted share units.
Summary
- Mark A. Gardner, SVP of Molecular Gen & Oncol at Quest Diagnostics, reported a transaction involving the company's common stock.
- On February 28, 2024, Gardner sold 262 shares at a price of $126.36 per share to satisfy tax obligations related to the vesting of restricted share units.
- Following the transaction, Gardner directly owns 4,793 shares of Quest Diagnostics common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine transaction to cover tax obligations.
Industry Context
This is a routine Form 4 filing, indicating an insider transaction. Such filings are common and provide transparency into the trading activities of company executives. The sale appears to be related to tax obligations, which is a typical reason for such transactions.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a small sale of shares by an executive.
Key Dates
| Date | Description |
|---|---|
| 02/28/2024 | Date of transaction: Sale of common stock. |
| 03/01/2024 | Date of signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.